Bioactivity of Dental Restorative Materials: FDI Policy Statement.


Journal

International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 09 11 2022
accepted: 20 11 2022
pubmed: 29 12 2022
medline: 21 1 2023
entrez: 28 12 2022
Statut: ppublish

Résumé

The term bioactivity is being increasingly used in medicine and dentistry. Due to its positive connotation, it is frequently utilised for advertising dental restorative materials. However, there is confusion about what the term means, and concerns have been raised about its potential overuse. Therefore, FDI decided to publish a Policy Statement about the bioactivity of dental restorative materials to clarify the term and provide some caveats for its use in advertising. Background information for this Policy Statement was taken from the current literature, mainly from the PubMed database and the internet. Bioactive restorative materials should have beneficial/desired effects. These effects should be local, intended, and nontoxic and should not interfere with a material's principal purpose, namely dental tissue replacement. Three mechanisms for the bioactivity of such materials have been identified: purely biological, mixed biological/chemical, or strictly chemical. Therefore, when the term bioactivity is used in an advertisement or in a description of a dental restorative material, scientific evidence (in vitro or in situ, and preferably in clinical studies) should be provided describing the mechanism of action, the duration of the effect (especially for materials releasing antibacterial substances), and the lack of significant adverse biological side effects (including the development and spread of antimicrobial resistance). Finally, it should be documented that the prime purpose, for instance, to be used to rebuild the form and function of lost tooth substance or lost teeth, is not impaired, as demonstrated by data from in vitro and clinical studies. The use of the term bioactive dental restorative material in material advertisement/information should be restricted to materials that fulfil all the requirements as described in the FDI Policy Statement.

Identifiants

pubmed: 36577639
pii: S0020-6539(22)00267-2
doi: 10.1016/j.identj.2022.11.012
pmc: PMC9875272
pii:
doi:

Substances chimiques

Dental Materials 0
Composite Resins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-27

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None disclosed.

Références

Odontology. 2021 Apr;109(2):303-312
pubmed: 33263826
Acta Biomater. 2020 Jan 1;101:69-101
pubmed: 31542502
Int Endod J. 2012 May;45(5):439-48
pubmed: 22188368
Materials (Basel). 2022 Jun 07;15(12):
pubmed: 35744101
Sci Rep. 2017 Jan 09;7:39654
pubmed: 28067250
Aust Endod J. 2018 Apr;44(1):60-65
pubmed: 29168274
Microorganisms. 2022 Mar 04;10(3):
pubmed: 35336136
RSC Adv. 2022 Jan 26;12(6):3454-3464
pubmed: 35425384
Dent Mater. 2019 Feb;35(2):335-343
pubmed: 30527586
Histochem J. 2000 Aug;32(8):489-94
pubmed: 11095074
Acta Biomater. 2018 Jul 15;75:3-10
pubmed: 29772346
J Endod. 2020 Sep;46(9S):S161-S174
pubmed: 32950188
Dent Mater. 2022 Jan;38(1):2-6
pubmed: 34893350
Arch Oral Biol. 2021 Jul;127:105148
pubmed: 34022546
J Dent. 2014 Jun;42 Suppl 1:S12-20
pubmed: 24993850
Br Dent J. 2022 May;232(9):653-657
pubmed: 35562467
Dent Mater. 2016 Jan;32(1):73-81
pubmed: 26621028
Dent Mater. 2014 Jul;30(7):709-15
pubmed: 24793199
Ann N Y Acad Sci. 1988;523:54-71
pubmed: 2837945
J Esthet Restor Dent. 2014 Jan-Feb;26(1):14-26
pubmed: 24341542
Dent Mater. 2019 Jan;35(1):24-35
pubmed: 30269862
Monogr Oral Sci. 2021;29:155-194
pubmed: 33427213
Int Endod J. 2012 Jun;45(6):571-9
pubmed: 22469093
Sci Rep. 2019 Mar 14;9(1):4457
pubmed: 30872775
Am J Dent. 2018 Nov 15;31(Sp Is B):32B-36B
pubmed: 31099210
Materials (Basel). 2020 May 31;13(11):
pubmed: 32486416
Am J Dent. 2018 Nov 15;31(Sp Is B):2B
pubmed: 31099204
Drug Deliv. 2022 Dec;29(1):561-573
pubmed: 35156501
Clin Oral Investig. 2021 Aug;25(8):5009-5024
pubmed: 33638052
Dent Mater. 2014 Jan;30(1):77-96
pubmed: 23927881
Int Dent J. 2018 Oct;68(5):299-305
pubmed: 29786135
Antibiotics (Basel). 2021 Nov 04;10(11):
pubmed: 34827283
J Dent Res. 2013 Jul;92(7 Suppl):16S-22S
pubmed: 23690353
Acta Odontol Scand. 1999 Dec;57(6):325-9
pubmed: 10777135
Clin Oral Investig. 2022 May;26(5):4031-4047
pubmed: 35029747
J Mater Sci Mater Med. 2006 Nov;17(11):967-78
pubmed: 17122907
Acta Biomater. 2010 Nov;6(11):4181-8
pubmed: 20493974
Dent Mater. 2011 Jul;27(7):631-6
pubmed: 21501862
J Endod. 2017 Nov;43(11):1786-1791
pubmed: 28822566
Croat Med J. 2016 Oct 31;57(5):465-473
pubmed: 27815937
Crit Rev Oral Biol Med. 2004 Jan 1;15(1):13-27
pubmed: 14761897
Int Endod J. 2006 Oct;39(10):747-54
pubmed: 16948659
Dent Mater J. 2009 Jan;28(1):11-9
pubmed: 19280964
Clin Oral Investig. 2001 Sep;5(3):139-47
pubmed: 11642557
Dent Mater J. 2022 Jul 30;41(4):560-566
pubmed: 35321976
Dent Mater. 2020 Oct;36(10):1322-1331
pubmed: 32814619
Materials (Basel). 2022 Mar 09;15(6):
pubmed: 35329471
J Appl Biomater Funct Mater. 2015 Jan-Mar;13(1):43-60
pubmed: 25199071
Clin Oral Investig. 2011 Feb;15(1):1-2
pubmed: 21234623
J Endod. 2017 Sep;43(9S):S7-S11
pubmed: 28844306
Dent Mater. 2019 Dec;35(12):1757-1768
pubmed: 31699444
J Endod. 2010 May;36(5):814-9
pubmed: 20416425
J Endod. 2017 Nov;43(11):1806-1820
pubmed: 28822564
J Dent. 2007 Aug;35(8):636-42
pubmed: 17566626
J Dent. 2022 Jul;122:104140
pubmed: 35490839
Dent Mater. 2013 Nov;29(11):1139-48
pubmed: 24050766
J Endod. 2014 Apr;40(4 Suppl):S2-5
pubmed: 24698689
Dent Mater. 2018 May;34(5):693-694
pubmed: 29571660
Biomater Sci. 2018 Dec 18;7(1):287-295
pubmed: 30468214

Auteurs

Gottfried Schmalz (G)

Department of Conservative Dentistry and Periodontology, University Hospital Regensburg, Regensburg, Germany; Department of Periodontology, University of Bern, Bern, Switzerland. Electronic address: Gottfried.schmalz@ukr.de.

Reinhard Hickel (R)

Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich, Munich, Germany.

Richard Bengt Price (RB)

Department of Dental Clinical Sciences, Faculty of Dentistry, Dalhousie University, Halifax, Nova Scotia, Canada.

Jeffrey A Platt (JA)

Department of Biomedical Sciences and Comprehensive Care, Division of Dental Biomaterials, Indiana University School of Dentistry, IUPUI, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH